About: European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2004 (uk) artículu científicu espublizáu n'avientu de 2004 (ast) scientific article published on 01 December 2004 (en)
publication date	wds:Q81073392-9F95B8E5-3BB8-4CD8-8AE2-C05A7FF81355
publication date	2004-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81073392-1A1198CD-A371-472E-A270-9BC3AE04E4B6 wds:Q81073392-240FACE2-4069-41B0-9085-7D9246BF6182 wds:Q81073392-457DBCE9-1D07-4247-98BC-3E94EA10F063 wds:Q81073392-B7473CBA-0779-48D7-91EA-1512569AB5CC wds:Q81073392-CB4EADC5-E808-477B-887E-BA88912BD7BA wds:Q81073392-E9AAFBD3-32A0-4F6F-AC6C-0D7829F049EB
author name string	Carli M Oberlin O Koscielniak E Treuner J Pinkerton R Tridello G
rdfs:label	European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (en) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (nl)
skos:prefLabel	European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (en) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (nl)
name	European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (en) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (nl)
author	wds:Q81073392-7E139037-3DD5-4054-B648-32F8C2A11B31 wds:Q81073392-E61AED27-BCD1-4B2A-B4A0-4282E706C986 wds:Q81073392-F4C6C77F-323B-4B77-A8D0-5E64B243ECA3 wds:Q81073392-FC157261-41A7-4D7A-9A30-2C224C9DBE78
author	Alberto Garaventa Gianni Bisogno Raffaella Colombatti Michael Stevens
title	wds:Q81073392-FC2D6DDB-F26F-465F-8685-582318F6FABF
title	European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (en)
page(s)	wds:Q81073392-29E3D102-D6CB-408C-AEE1-591EFF3EF74F
page(s)	4787-4794
instance of	wds:Q81073392-149B05BF-CDD6-4D3A-A9EB-87145C0030B5
instance of	scholarly article
main subject	wds:Q81073392-36E68119-A211-4F70-9067-A5D405F8151B
main subject	rhabdomyosarcoma
PubMed ID	wds:Q81073392-12EBA661-E87D-4DDA-B2AA-1136CB38DFC0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15570080
PubMed ID	15570080
published in	wds:Q81073392-A402AFBD-10D2-426E-99A4-8C55EFF5CE25
published in	Journal of Clinical Oncology
issue	wds:Q81073392-EE3F1BF1-EE91-4E31-8D72-2D1E14479099
volume	wds:Q81073392-BA83E1DF-E0E9-48BD-B429-B0775A4CCB7F
issue	23
volume	22
DOI	wds:Q81073392-29303E83-A733-4B77-B418-FA1C4B2C6D2D
DOI	http://dx.doi.org/10.1200/JCO.2004.04.083
DOI	10.1200/JCO.2004.04.083
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81073392
is cites work of	Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas High dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience Rhabdomyosarcoma in adolescents Common musculoskeletal tumors of childhood and adolescence RAS signaling dysregulation in human embryonal Rhabdomyosarcoma Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. Clinical relevance of molecular genetics to paediatric sarcomas Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases Imaging findings in noncraniofacial childhood rhabdomyosarcoma. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis. Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee Outcome for children with metastatic solid tumors over the last four decades Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma. Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial. Current and Future Treatment Strategies for Rhabdomyosarcoma Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling Clinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonal rhabdomyosarcoma High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Initial response to treatment was highly associated with the prognosis of childhood rhabdomyosarcoma: a retrospective analysis of a single center experience in Korea Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma. Integrin-linked kinase: both Jekyll and Hyde in rhabdomyosarcoma Surgical treatment of pulmonary metastases in pediatric solid tumors. Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells. Significance of local treatment in patients with metastatic soft tissue sarcoma Embryonal rhabdomyosarcoma: A rare oral tumor A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model. Results of RS-99 protocol for childhood solid tumors Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group MicroRNA-29 family inhibits rhabdomyosarcoma formation and progression by regulating GEFT function Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Metastasectomy in pediatric patients: indications, technical tips and outcomes. Breast relapse after metastatic alveolar rhabdomyosarcoma: Is it an incurable entity?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software